Journal of International Oncology››2016,Vol. 43››Issue (11): 822-825.doi:10.3760/cma.j.issn.1673-422X.2016.11.005
Previous ArticlesNext Articles
Li Chengyi, Zhao Guibin, Liu Liying, Yang Xuxiong
Received:
2016-04-11Online:
2016-11-08Published:
2016-11-02Contact:
Zhao Guibin E-mail:602362384@qq.comLi Chengyi, Zhao Guibin, Liu Liying, Yang Xuxiong. Appliation of oncoplastic breast-conserving reconstruction for patients with earlystage breast cancer[J]. Journal of International Oncology, 2016, 43(11): 822-825.
[1] 曹旭晨. 整形保乳手术——乳腺外科个体化治疗的新方向[J]. 中国普外基础与临床杂志, 2013, 20(8): 838-841. DOI: 10.7507/10079424.20130215. [2] Veiga DF, VeigaFilho J, Ribeiro LM, et al. Qualityoflife and selfesteem outcomes after oncoplastic breastconserving surgery[J]. Plast Reconstr Surg, 2010, 125(3): 811-817. DOI: 10.1097/PRS.0b13e3181ccdac5. [3] Masetti R, Di Leone A, Franceschini G, et al. Oncoplastic techniques in the conservative surgical treatment of breast cancer: an overview[J]. Breast J, 2006, 12(5 Suppl 2): S174-180. DOI: 10.1111/j.1075-122X.2006.00331.x. [4] 张保宁. 乳腺癌保乳手术的研究进展[J]. 中国普外基础与临床杂志, 2005, 12(3): 204206. [5] Rainsbury MR. Surgery insight:oncoplastic breastconserving reconstruction indication, benefits, choices and outcomes[J]. Nat Clin Pract Oncol, 2007, 4(11): 657-664. [6] 康骅, 朱江, 海涛, 等. 乳房整形技术在乳腺癌保乳手术中的应用体会[J]. 中国普外基础与临床杂志, 2011, 18(9): 917-921. [7] 王会元, 李非, 罗斌, 等. 整形外科技术在乳腺癌保乳手术中的应用[J]. 中华普通外科杂志, 2012, 27(4): 314-317. DOI: 10.3760/cma.j.issn.1007-631X.2012.04.018. [8] Meretoja TJ, Svarvar C, Jahkola TA. Outcome of oncoplasfic breast surgery in 90 prospective patients[J]. Am J Surg, 2010, 200(2): 224-228. DOI: 10.1016/j.amjsurg.2009.09.026. [9] Fitoussi AD, Berry MG, Famà F, et al. Oncoplastic breast surgery for cancer: analysis of 540 consecutive cases[J]. Plast Reconstr Surg, 2010, 125(2): 454462. DOI: 10.1097/PRS.0b013e3181c82d3e. |
[1] | Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369. |
[2] | Sa Qiang, Xu Hangcheng, Wang Jiayu.Advances in immunotherapy for breast cancer[J]. Journal of International Oncology, 2024, 51(4): 227-234. |
[3] | Yang Zhi, Lu Yiqiao, Gu Huayan, Ding Jialing, Guo Guilong.Research progress of tumor microenvironment mediated drug resistance in targeted therapy of breast cancer[J]. Journal of International Oncology, 2024, 51(4): 235-238. |
[4] | Chen Boguang, Wang Sugui, Zhang Yongjie.Role of serum cholinesterase and inflammatory markers in the prognosis of stage ⅠA -ⅢA breast cancer[J]. Journal of International Oncology, 2024, 51(2): 73-82. |
[5] | Gu Huayan, Zhu Teng, Guo Guilong.Breast microbiota and breast cancer: present and future[J]. Journal of International Oncology, 2024, 51(1): 55-58. |
[6] | Wang Jing, Xu Wenting.Value of NLR, CEA combined with coagulation indicators in the differential diagnosis of benign and malignant breast nodules with a diameter ≤ 1.0 cm[J]. Journal of International Oncology, 2023, 50(9): 520-526. |
[7] | Feng Chengtian, Huang Furong, Cao Shiyu, Wang Jianyu, Nanding Abiyasi, Jiang Yongdong, Zhu Juanying.Relationships between HER2 protein expression and imaging features in HER2 positive breast cancer patients[J]. Journal of International Oncology, 2023, 50(9): 527-531. |
[8] | Feng Dongxu, Wu Wei, Gao Pingfa, Wang Jun, Shi Lijuan, Chen Dawei, Li Wenbing, Zhang Meifeng.Effects of miR-451 on glycolysis and apoptosis of breast cancer cells by regulating Rho/ROCK1 pathway[J]. Journal of International Oncology, 2023, 50(8): 449-456. |
[9] | Pan Shulan, Liu Chang, He Ping.Effect of fritinib on angiogenesis, tumor growth and IRE1-ASK1-JNK pathway in triple negative breast cancer[J]. Journal of International Oncology, 2023, 50(8): 457-462. |
[10] | Wang Wende, Zeng De.Research progress on the mechanism of endocrine therapy resistance for breast cancer[J]. Journal of International Oncology, 2023, 50(6): 352-356. |
[11] | Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai.Research progress on the application of combining radiotherapy and systemic therapy in breast cancer[J]. Journal of International Oncology, 2023, 50(6): 362-367. |
[12] | Zhu Jun, Huang Meijin, Li Yuan, Liu Zegang, Xun Xin, Chen Hong.Research progress on targeted therapy of breast cancer with low expression of HER2[J]. Journal of International Oncology, 2023, 50(4): 236-240. |
[13] | Zhou Ting, Xu Shaohua, Mei Lin.Efficacy and safety of bevacizumab combined with capecitabine in the treatment of advanced breast cancer[J]. Journal of International Oncology, 2023, 50(3): 144-149. |
[14] | Li Lixi, Zhang Di, Luo Yang, Ma Fei.Clinical application of PARP inhibitors in breast cancer[J]. Journal of International Oncology, 2023, 50(2): 91-96. |
[15] | Geng Rui, Ma Junqiang, Guo Qiang, Niu Zhaofeng.Tendency of elderly patients with breast cancer to choose comprehensive treatment mode and its influencing factors[J]. Journal of International Oncology, 2023, 50(11): 650-654. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||